Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 2.83B | $ 2.23B | $ 2.04B | $ 1.37B | $ 1.01B |
Total Assets | $ 4.70B | $ 3.99B | $ 3.57B | $ 2.87B | $ 2.64B |
Total Debt | $ 1.58B | $ 1.57B | $ 1.77B | $ 1.32B | $ 1.09B |
Net Debt | $ -1.25B | $ -658.10M | $ -268.70M | $ -52.20M | $ 86.70M |
Total Liabilities | $ 3.40B | $ 3.10B | $ 2.65B | $ 1.91B | $ 1.89B |
Stockholders Equity | $ 1.29B | $ 896.60M | $ 922.60M | $ 964.20M | $ 750.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |